University of California; Los Angeles
Los Angeles, United States
Kevin Li is a current student at the University of California, Los Angeles, pursuing an undergraduate degree in Microbiology, Immunology, and Molecular Genetics. He works in the lab of Dr. Robert Prins investigating immunotherapy in glioblastoma (GBM), specifically the effect of hypomethylating agents such as decitabine on the expression of targetable antigens in GBM.